SHC (Sotera Health Co) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 07, 2026)


SHC Sotera Health Co SHC
74 GF Score
Price $17.86
GF Value $16.34
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sotera Health Co 5-Year Yield-on-Cost %?

Sotera Health Co SHC -0.39% 74 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. GuruFocus rates SHC with a GF Score™ of 74/100 and a GF Value™ of $16.34 (Fairly Valued). The stock has 4 warning signs investors should review. Among 64 Medical Diagnostics & Research companies, Sotera Health Co ranks worse than 1562498.44% on this metric.

Sotera Health Co's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Sotera Health Co's 5-Year Yield-on-Cost % or its related term are showing as below:



SHC's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.365
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Sotera Health Co  (NAS:SHC) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Sotera Health Co 5-Year Yield-on-Cost % Related Terms


SHC vs VCYT, RDNT, BLLN: 5-Year Yield-on-Cost % Comparison

For the Diagnostics & Research subindustry, Sotera Health Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sotera Health Co 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sotera Health Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sotera Health Co's 5-Year Yield-on-Cost % falls into.


SHC
74GF Score
Sotera Health Co SHC
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sotera Health Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sotera Health Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Sotera Health Co (SHC) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sotera Health Co and its competitors. According to the industry distribution chart, Sotera Health Co ranks #999999 out of 64 companies in the Medical Diagnostics & Research industry.
Is Sotera Health Co's 5-Year Yield-on-Cost % too high?
Sotera Health Co's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Sotera Health Co ranks #999999 out of 64 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Sotera Health Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotera Health Co's 5-Year Yield-on-Cost % compare to VCYT and RDNT?
According to the Medical Diagnostics & Research industry distribution chart, Sotera Health Co ranks #999999 out of 64 companies for 5-Year Yield-on-Cost %. This places Sotera Health Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.37, based on 64 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sotera Health Co and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sotera Health Co's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotera Health Co stock overvalued right now?
Based on GuruFocus' analysis, Sotera Health Co (SHC) is currently considered Fairly Valued. The stock's GF Value™ is $16.34, compared to a current price of $17.86 — trading 9.3% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Sotera Health Co's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sotera Health Co (SHC), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sotera Health Co (SHC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued. The current stock price of $17.86 is trading 9.3% above its estimated GF Value™ of $16.34. GuruFocus considers Sotera Health Co to be Fairly Valued.

Key valuation signals for SHC:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $16.34 vs. price of $17.86 (9.3% above fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sotera Health Co Business Description

Address 9100 South Hills Boulevard, Suite 300, Broadview Heights, OH, USA, 44147
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
74GF Score

Get the complete analysis for SHC

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.86
Price
$16.34
GF Value